USPH Other Current Liab vs Good Will Analysis
USPH Stock | USD 98.76 1.68 1.73% |
US Physicalrapy financial indicator trend analysis is much more than just breaking down US Physicalrapy prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether US Physicalrapy is a good investment. Please check the relationship between US Physicalrapy Other Current Liab and its Good Will accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
Other Current Liab vs Good Will
Other Current Liab vs Good Will Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of US Physicalrapy Other Current Liab account and Good Will. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between US Physicalrapy's Other Current Liab and Good Will is -0.5. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Good Will in the same time period over historical financial statements of US Physicalrapy, assuming nothing else is changed. The correlation between historical values of US Physicalrapy's Other Current Liab and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of US Physicalrapy are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Other Current Liab i.e., US Physicalrapy's Other Current Liab and Good Will go up and down completely randomly.
Correlation Coefficient | -0.5 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Other Current Liab
Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Most indicators from US Physicalrapy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Enterprise Value Over EBITDA is increasing as compared to previous years. The US Physicalrapy's current Enterprise Value Multiple is estimated to increase to 20.15, while Selling General Administrative is projected to decrease to under 26.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 117.2M | 112.0M | 112.0M | 117.6M | Total Revenue | 495.0M | 553.1M | 604.8M | 635.0M |
US Physicalrapy fundamental ratios Correlations
Click cells to compare fundamentals
US Physicalrapy Account Relationship Matchups
High Positive Relationship
High Negative Relationship
US Physicalrapy fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 560.8M | 594.4M | 749.4M | 858.2M | 997.2M | 1.0B | |
Other Current Liab | 30.9M | 26.5M | 12.5M | 3.4M | 18.7M | 11.7M | |
Total Current Liabilities | 60.6M | 93.5M | 83.5M | 85.5M | 102.2M | 107.3M | |
Total Stockholder Equity | 240.3M | 276.2M | 295.6M | 315.8M | 476.2M | 500.0M | |
Property Plant And Equipment Net | 103.7M | 103.3M | 119.4M | 127.8M | 129.5M | 136.0M | |
Net Debt | 114.3M | 78.1M | 194.5M | 263.7M | 105.8M | 111.1M | |
Retained Earnings | 184.4M | 212.0M | 223.6M | 232.9M | 223.8M | 235.0M | |
Accounts Payable | 2.5M | 1.3M | 6.5M | 6.5M | 3.9M | 4.1M | |
Cash | 23.5M | 32.9M | 28.6M | 31.6M | 152.8M | 160.5M | |
Non Current Assets Total | 475.5M | 506.7M | 654.3M | 746.9M | 763.9M | 802.1M | |
Cash And Short Term Investments | 23.5M | 32.9M | 28.6M | 31.6M | 152.8M | 160.5M | |
Net Receivables | 56.1M | 41.9M | 46.3M | 51.9M | 51.9M | 27.3M | |
Common Stock Shares Outstanding | 12.8M | 12.8M | 12.9M | 13.0M | 14.2M | 12.9M | |
Liabilities And Stockholders Equity | 560.8M | 594.4M | 749.4M | 858.2M | 997.2M | 1.0B | |
Other Current Assets | 5.8M | 12.8M | 20.3M | 27.7M | 28.7M | 30.1M | |
Other Stockholder Equity | 55.8M | 64.0M | 71.1M | 78.7M | 249.5M | 261.9M | |
Total Liab | 181.4M | 184.4M | 297.0M | 373.6M | 345M | 362.3M | |
Property Plant And Equipment Gross | 103.7M | 103.3M | 97.9M | 208.0M | 214.4M | 225.1M | |
Total Current Assets | 85.4M | 87.6M | 95.2M | 111.3M | 233.4M | 245.0M | |
Short Long Term Debt Total | 137.8M | 111.0M | 223.1M | 295.3M | 258.6M | 271.5M | |
Non Currrent Assets Other | 1.5M | 1.5M | (28.7M) | (26.4M) | 2.8M | 3.0M | |
Non Current Liabilities Total | 120.8M | 90.9M | 213.5M | 288.1M | 242.8M | 255.0M | |
Short Term Debt | 27.2M | 59.9M | 61.8M | 75.3M | 78.2M | 82.1M | |
Intangible Assets | 52.6M | 56.3M | 86.4M | 108.8M | 109.7M | 115.2M | |
Good Will | 317.7M | 345.6M | 434.7M | 494.1M | 509.6M | 484.1M | |
Common Stock Total Equity | 148K | 149K | 150K | 151K | 173.7K | 144.3K | |
Common Stock | 149K | 150K | 151K | 152K | 172K | 147.0K | |
Other Assets | 1.5M | 14.1M | 1.6M | 1.6M | 1.9M | 2.1M | |
Long Term Debt | 50.4M | 16.6M | 117.6M | 175.8M | 139.0M | 145.9M | |
Property Plant Equipment | 22.1M | 21.7M | 119.4M | 127.8M | 146.9M | 154.3M | |
Other Liab | 10.2M | 12.3M | 21.7M | 34.3M | 39.5M | 41.5M | |
Net Tangible Assets | 7.7M | 6.6M | (225.5M) | (287.1M) | (258.4M) | (245.4M) | |
Noncontrolling Interest In Consolidated Entity | 930K | 1.4M | 1.5M | 1.6M | 1.4M | 1.3M | |
Retained Earnings Total Equity | 167.4M | 184.4M | 212.0M | 224.4M | 258.1M | 158.3M | |
Long Term Debt Total | 38.4M | 50.4M | 16.6M | 117.6M | 135.2M | 142.0M |
Currently Active Assets on Macroaxis
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 1.75 | Earnings Share 0.88 | Revenue Per Share 42.489 | Quarterly Revenue Growth 0.12 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.